A Prospective, Randomized, Trial to Investigate the Effect of Continued Adefovir Versus Combination Regimens of Telbivudine Plus Adefovir, and Telbivudine Plus Tenofovir in Patients With Chronic Hepatitis B and Suboptimal Viral Suppression (PROACTIV Study)

Trial Profile

A Prospective, Randomized, Trial to Investigate the Effect of Continued Adefovir Versus Combination Regimens of Telbivudine Plus Adefovir, and Telbivudine Plus Tenofovir in Patients With Chronic Hepatitis B and Suboptimal Viral Suppression (PROACTIV Study)

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2015

At a glance

  • Drugs Adefovir; Telbivudine
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Acronyms PROACTIV Study
  • Sponsors Idenix Pharmaceuticals; Novartis
  • Most Recent Events

    • 11 May 2008 Status changed from initiated to withdrawn prior to recruitment, as reported by ClinicalTrials.gov.
    • 11 Jan 2008 Status changed from recruiting to initiated.
    • 15 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top